Bracco-Eisai Co., Ltd.

NEW YORK, Feb. 13, 2023 /PRNewswire/ -- The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability. Continue Reading Source: ReportLinker Research Read the full report: Global Imaging Agents Market to Reach $13.4 Billion by 2030 In the changed post COVID-19 business landscape, the global market for Imaging Agents estimated at US$9.4 Billion in the year 2022, is projected to reach a revised size of US$13.4 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2022-2030. Diagnostic Radiopharmaceuticals, one of the segments analyzed in the report, is projected to record a 5.8% CAGR and reach US$7.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the X-Ray / CT segment is readjusted to a revised 3.3% CAGR for the next 8-year period. The U.S. Market is Estimated at $2.6 Billion, While China is Forecast to Grow at 7.9% CAGR The Imaging Agents market in the U.S. is estimated at US$2.6 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 7.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.2% and 3.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.8 Billion by the year 2030. Select Competitors (Total 23 Featured) - Aytu BioScience Inc. - Bayer Healthcare Pharmaceuticals - Bracco Diagnostics Inc. - Curium - Daiichi Sankyo Company Limited - Eli Lilly - GE Healthcare - Guerbet Group - Lantheus Medical Imaging Inc. - Piramal Imaging SA Read the full report: I. METHODOLOGY II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Influencer Market Insights World Market Trajectories Imaging Agents: Providing Brighter and Clearer Images for Effective Clinical Diagnosis Recent Market Activity Major Growth Drivers in a Nutshell Growing Need for Early Disease Diagnosis Fosters Demand for Imaging Agents Select Market Growth Restraints Contrast Media: Giving Way to Contemporary Offshoots X-ray/CT Segment Continues to Lead Contrast Media Market Developed Economies Face Threat from Rising Demand for Contrast Agents in Asia-Pacific Diagnostic Radiopharmaceuticals to Outdo Contrast Media Nuclear Medicine: A Potential Growth Avenue for Dx Radiopharmaceuticals Select PET and SPECT Radioisotopes Used in Nuclear Medicine Select Cardiology and Oncology Radiopharmaceuticals Developed Markets Rule the Imaging Agents Market, Developing Regions to Spearhead Future Growth Imaging Agents - Global Key Competitors Percentage Market Share in 2022 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS Aytu BioScience, Inc. (USA) Bayer Healthcare Pharmaceuticals (Germany) Bracco Diagnostics, Inc. (USA) Curium (France) Daiichi Sankyo Company Limited (Japan) Bracco-Eisai Co., Ltd (Japan) Eli Lilly and Company (USA) GE Healthcare (UK) Guerbet Group (France) Lantheus Medical Imaging, Inc. (USA) Piramal Imaging SA (Switzerland) 3. MARKET TRENDS & DRIVERS Sustained Expansion of Molecular Imaging Platform Presents Positive Outlook Novel Radiopharmaceuticals Add New Dimensions to Molecular Imaging Latest Radiopharmaceuticals to Benefit Molecular Imaging Microbubbles/Ultrasound Contrast Agents Set for Strong Growth Growing Interest in Image Guided Surgery Offers New Opportunities Role of Near-Infrared Contrast Agents for Image Guided Surgery Fluorescence Optical Imaging - Opens New Avenues Coronary CT Angiography Opens Up Opportunities for Contrast Agents List of Iodine-Containing Contrast Agents for Coronary CT Angiography Targeted Imaging - A Game Changer in the Making Rising Clinical Acceptance of MRI Systems Augurs Well for Contrast Agents Market Researchers Develop Iron Oxide-based Contrast Agent for MRI Nanomaterials Taking the Center Stage New Nanoparticle Contrast Agents on the Horizon Show Promise Gadolinium Coated Nanoparticles - A Promising Imaging Agent Growing Focus on Development of Gold Nanoparticles in X-Ray Imaging Imaging Agents Make a Welcome Impact in the Field of Alzheimer?s Disease List of FDA Approved Alzheimer's Diagnostic Imaging Agents Contrast-Enhanced Tomosynthesis Expands Opportunities Hyperpolarized Gases as Contrast Agents Multi-Modal Imaging: Combating Contrast Medium Inconsistencies Falling Prices Turn on the Heat Ultrasound Contrast Agents in Diagnosis of Kidney Ailments PET: A Prime Growth Driver for Diagnostic Radiopharmaceuticals Innovative Radiotracers to Boost Cardiac Applications for SPECT and PET Modalities A Peek at Global CVD Stats Echocardiography Examinations - Improving Diagnostic Quality through Contrast Agents Opportunities on Rise for Fluorine-Based Myocardial Perfusion Agents Unfounded Fears of Radiation Exposure: A Major Concern for Nuclear Diagnostics Rising Incidence of Cancer - A Major Growth Driver World Cancer Statistics - Incidence and Mortality Data Improving Healthcare Expenditure to Foster Growth Aging Population - A Vital Demography A Peek into Pricing Dynamics Packaging of Contrast Agents - An Overview Global Supply Shortages Restrains Radiopharmaceuticals Market Price Sensitivity & Competition from Alternatives Lack of Dosage Standards for Pediatric Patients Limits Radiopharmaceutical Efficacy Reimbursement Scenario 4. GLOBAL MARKET PERSPECTIVE Table 1: World Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR Table 2: World Historic Review for Imaging Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 3: World 18-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2023 & 2030 Table 4: World Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR Table 5: World Historic Review for Diagnostic Radiopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 6: World 18-Year Perspective for Diagnostic Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030 Table 7: World Recent Past, Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR Table 8: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 9: World 18-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030 Table 10: World Recent Past, Current & Future Analysis for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR Table 11: World Historic Review for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 12: World 18-Year Perspective for Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030 Table 13: World Recent Past, Current & Future Analysis for X-Ray / CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR Table 14: World Historic Review for X-Ray / CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 15: World 18-Year Perspective for X-Ray / CT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030 Table 16: World Imaging Agents Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030 III. MARKET ANALYSIS UNITED STATES Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E) Table 17: USA Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 18: USA Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 19: USA 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 CANADA Table 20: Canada Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 21: Canada Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 22: Canada 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 JAPAN Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E) Table 23: Japan Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 24: Japan Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 25: Japan 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 CHINA Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E) Table 26: China Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 27: China Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 28: China 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 EUROPE Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E) Table 29: Europe Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR Table 30: Europe Historic Review for Imaging Agents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 31: Europe 18-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2023 & 2030 Table 32: Europe Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 33: Europe Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 34: Europe 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 FRANCE Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E) Table 35: France Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 36: France Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 37: France 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 GERMANY Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E) Table 38: Germany Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 39: Germany Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 40: Germany 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 ITALY Table 41: Italy Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 42: Italy Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 43: Italy 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 UNITED KINGDOM Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E) Table 44: UK Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 45: UK Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 46: UK 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 SPAIN Table 47: Spain Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 48: Spain Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 49: Spain 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 RUSSIA Table 50: Russia Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 51: Russia Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 52: Russia 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 REST OF EUROPE Table 53: Rest of Europe Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 54: Rest of Europe Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 55: Rest of Europe 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 ASIA-PACIFIC Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E) Table 56: Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR Table 57: Asia-Pacific Historic Review for Imaging Agents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 58: Asia-Pacific 18-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2023 & 2030 Table 59: Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 60: Asia-Pacific Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 61: Asia-Pacific 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 AUSTRALIA Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E) Table 62: Australia Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 63: Australia Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 64: Australia 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 INDIA Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E) Table 65: India Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 66: India Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 67: India 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 SOUTH KOREA Table 68: South Korea Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 69: South Korea Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 70: South Korea 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 REST OF ASIA-PACIFIC Table 71: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 72: Rest of Asia-Pacific Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 73: Rest of Asia-Pacific 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 LATIN AMERICA Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E) Table 74: Latin America Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR Table 75: Latin America Historic Review for Imaging Agents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 76: Latin America 18-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2023 & 2030 Table 77: Latin America Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 78: Latin America Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 79: Latin America 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 ARGENTINA Table 80: Argentina Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 81: Argentina Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 82: Argentina 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 BRAZIL Table 83: Brazil Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 84: Brazil Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 85: Brazil 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 MEXICO Table 86: Mexico Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 87: Mexico Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 88: Mexico 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 REST OF LATIN AMERICA Table 89: Rest of Latin America Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 90: Rest of Latin America Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 91: Rest of Latin America 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 MIDDLE EAST Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E) Table 92: Middle East Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR Table 93: Middle East Historic Review for Imaging Agents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 94: Middle East 18-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2023 & 2030 Table 95: Middle East Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 96: Middle East Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 97: Middle East 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 IRAN Table 98: Iran Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 99: Iran Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 100: Iran 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 ISRAEL Table 101: Israel Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 102: Israel Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 103: Israel 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 SAUDI ARABIA Table 104: Saudi Arabia Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 105: Saudi Arabia Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 106: Saudi Arabia 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 UNITED ARAB EMIRATES Table 107: UAE Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR Table 108: UAE Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR Table 109: UAE 18-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2023 & 2030 REST OF MIDDLE EAST Please contact our Customer Support Center to get the complete Table of Contents Read the full report: About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001 SOURCE Reportlinker